Suppr超能文献

大肠杆菌DNA拓扑异构酶I与Tn5转座酶共同纯化,且Tn5转座酶抑制拓扑异构酶I。

Escherichia coli DNA topoisomerase I copurifies with Tn5 transposase, and Tn5 transposase inhibits topoisomerase I.

作者信息

Yigit H, Reznikoff W S

机构信息

Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

出版信息

J Bacteriol. 1999 May;181(10):3185-92. doi: 10.1128/JB.181.10.3185-3192.1999.

Abstract

Tn5 transposase (Tnp) overproduction is lethal to Escherichia coli. Genetic evidence suggested that this killing involves titration of E. coli topoisomerase I (Topo I). Here, we present biochemical evidence that supports this model. Tn5 Tnp copurifies with Topo I while nonkilling derivatives of Tnp, Delta37Tnp and Delta55Tnp (Inhibitor [Inh]), show reduced affinity or no affinity, respectively, for Topo I. In agreement with these results, the presence of Tnp, but not Delta37 or Inh derivatives of Tnp, inhibits the DNA relaxation activity of Topo I in vivo as well as in vitro. Other proteins, including RNA polymerase, are also found to copurify with Tnp. For RNA polymerase, reduced copurification with Tnp is observed in extracts from a topA mutant strain, suggesting that RNA polymerase interacts with Topo I and not Tnp.

摘要

Tn5转座酶(Tnp)过量表达对大肠杆菌具有致死性。遗传学证据表明,这种致死作用涉及对大肠杆菌拓扑异构酶I(Topo I)的滴定。在此,我们提供了支持该模型的生化证据。Tn5 Tnp与Topo I共纯化,而Tnp的非致死衍生物Delta37Tnp和Delta55Tnp(抑制剂[Inh])分别对Topo I显示出降低的亲和力或无亲和力。与这些结果一致,Tnp的存在而非Delta37或Tnp的Inh衍生物在体内和体外均抑制Topo I的DNA松弛活性。还发现其他蛋白质,包括RNA聚合酶,也与Tnp共纯化。对于RNA聚合酶,在topA突变株的提取物中观察到与Tnp的共纯化减少,这表明RNA聚合酶与Topo I相互作用而非与Tnp相互作用。

相似文献

1
Escherichia coli DNA topoisomerase I copurifies with Tn5 transposase, and Tn5 transposase inhibits topoisomerase I.
J Bacteriol. 1999 May;181(10):3185-92. doi: 10.1128/JB.181.10.3185-3192.1999.
6
Characterization of the Tn5 transposase and inhibitor proteins: a model for the inhibition of transposition.
J Bacteriol. 1993 Nov;175(21):6932-8. doi: 10.1128/jb.175.21.6932-6938.1993.
8
Defining characteristics of Tn5 Transposase non-specific DNA binding.
Nucleic Acids Res. 2006 May 22;34(9):2820-32. doi: 10.1093/nar/gkl179. Print 2006.
10
Trans-acting transposase mutant from Tn5.
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6072-6. doi: 10.1073/pnas.88.14.6072.

引用本文的文献

1
Type IA Topoisomerases as Targets for Infectious Disease Treatments.
Microorganisms. 2021 Jan 1;9(1):86. doi: 10.3390/microorganisms9010086.
2
Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4028-36. doi: 10.1128/AAC.00288-16. Print 2016 Jul.
3
An endogenous protein inhibitor, YjhX (TopAI), for topoisomerase I from Escherichia coli.
Nucleic Acids Res. 2015 Dec 2;43(21):10387-96. doi: 10.1093/nar/gkv1197. Epub 2015 Nov 8.
4
55.2, a phage T4 ORFan gene, encodes an inhibitor of Escherichia coli topoisomerase I and increases phage fitness.
PLoS One. 2015 Apr 14;10(4):e0124309. doi: 10.1371/journal.pone.0124309. eCollection 2015.
5
Roles of type 1A topoisomerases in genome maintenance in Escherichia coli.
PLoS Genet. 2014 Aug 7;10(8):e1004543. doi: 10.1371/journal.pgen.1004543. eCollection 2014 Aug.
6
Bacterial topoisomerase I as a target for discovery of antibacterial compounds.
Nucleic Acids Res. 2009 Feb;37(3):731-7. doi: 10.1093/nar/gkn936. Epub 2008 Nov 28.

本文引用的文献

1
A mechanism for Tn5 inhibition. carboxyl-terminal dimerization.
J Biol Chem. 1999 Jan 1;274(1):86-92. doi: 10.1074/jbc.274.1.86.
3
Functional characterization of the Tn5 transposase by limited proteolysis.
J Biol Chem. 1998 May 1;273(18):10908-13. doi: 10.1074/jbc.273.18.10908.
4
Tn5 in vitro transposition.
J Biol Chem. 1998 Mar 27;273(13):7367-74. doi: 10.1074/jbc.273.13.7367.
7
Target site selection in transposition.
Annu Rev Biochem. 1997;66:437-74. doi: 10.1146/annurev.biochem.66.1.437.
10
DNA transposition: from a black box to a color monitor.
Cell. 1995 Dec 29;83(7):1063-6. doi: 10.1016/0092-8674(95)90132-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验